[en] OBJECTIVES: To explore the in-vitro and in-vivo antimalarial potential of caffeic acid and derivatives. METHODS: Two common phenolic acids (caffeic acid and chlorogenic acid) were evaluated for in-vitro and in-vivo antiplasmodial activity in comparison with some semi-synthetic derivatives that were synthesized. An in-vitro assay based on plasmodial lactate dehydrogenase activity, and the classical in-vivo 5-day suppressive test from Peters on an artemisinin-resistant Plasmodium berghei strain was used. Parasitic stage sensitivity to ethyl caffeate was determined in this work. KEY FINDINGS: Phenolic acid esters derivatives showed better antiplasmodial activity than corresponding phenolic acids. The derivative with the highest in-vitro activity being caffeic acid ethyl ester, exhibiting an IC50 = 21.9 +/- 9.4 mum. Ethyl caffeate and methyl caffeate were then evaluated for antimalarial activity in vivo and ethyl caffeate showed a growth inhibition of 55% at 100 mg/kg. Finally, it seems that ethyl caffeate blocks the growth of young parasitic forms. CONCLUSIONS: Our study provides evidence for an antimalarial potential of caffeic acid derivatives which are common in several medicinal plants traditionally used against malaria. It also demonstrates the possibility to use such derivatives in the treatment of malaria.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Alson, Sylvain G.
Jansen, Olivia ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Cieckiewicz, Ewa ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Rakotoarimanana, Hajatiana
Rafatro, Herintsoa
Degotte, Gilles ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Francotte, Pierre ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Frederich, Michel ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Language :
English
Title :
In-vitro and in-vivo antimalarial activity of caffeic acid and some of its derivatives.
World malaria report 2017. Geneva: World Health Organization; 2017. DOI: ISBN 978-92-4-156552-3
Bellanger A-P et al. Malaria outbreak in French troops returning from Côte d'Ivoire. Scand J Infect Dis 2011; 43: 230–233
Partnership SCT. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 2015; 386: 31–45
Chiang Y-M et al. Ethyl caffeate suppresses NF-kappaB activation and its downstream inflammatory mediators, iNOS, COX-2, and PGE2 in vitro or in mouse skin. Br J Pharmacol 2005; 146: 352–363
Xu S et al. Ethyl caffeate ameliorates collagen-induced arthritis by suppressing Th1 immune response. J Immunol Res 2017; 2017: 7416792
Chalas J et al. Effect of ethyl esterification of phenolic acids on low-density lipoprotein oxidation. Biomed Pharmacother 2001; 55: 54–60
Gandhi GR et al. Antihyperglycemic activity and antidiabetic effect of methyl caffeate isolated from Solanum torvum Swartz. fruit in streptozotocin induced diabetic rats. Eur J Pharmacol 2011; 670: 623–631
Lim DY et al. (+)-2-(1-Hydroxyl-4-oxocyclohexyl) ethyl caffeate suppresses solar UV-induced skin carcinogenesis by targeting PI3K, ERK1/2, and p38. Cancer Prev Res (Phila) 2014; 7: 856–865
Balachandran C et al. Antimicrobial and antimycobacterial activities of methyl caffeate isolated from Solanum torvum Swartz. Fruit. Indian J Microbiol 2012; 52: 676–681
Gangan VD et al. Ethyl caffeate ether derivatives as future potential drug. J Pharm Res 2014; 88: 818–821
Herrmann K, Nagel CW. Occurrence and content of hydroxycinnamic and hydroxybenzoic acid compounds in foods. Crit Rev Food Sci Nutr 1989; 28: 315–347
De P et al. Cinnamic acid derivatives as anticancer agents – a review. Curr Med Chem 2011; 18: 1672–1703
Frederich M et al. Antiplasmodial activity of alkaloids from various Strychnos species. J Nat Prod 2002; 65: 1381–1386. https://doi.org/10.1021/NP020070E
Jonville MC et al. Dimeric bisindole alkaloids from the stem bark of Strychnos nux-vomica L. Phytochemistry 2013; 87: 157–163
Peters W, Robinson BL. The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides. Ann Trop Med Parasitol 1999; 93: 325–329
Cambie G et al. Chronotherapy of malaria: identification of drug-sensitive stage of parasite and timing of drug delivery for improved therapy. Ann Parasitol Hum Comp 1991; 66: 14–21
Montalvo-Alvarez AM et al. Experimental modifications of the circadian rythm of Plasmodium vinckei petteri following cryopreservation; probable resistance of the merozoïte to thawing. C R Acad Sci III 1988; 307: 5–10
Cambie G et al. [Timing niches of 3 species of Plasmodium coexisting in a rodent in Central Africa]. C R Acad Sci III 1990; 310: 183–188
Caillard V et al. Plasmodium vinckei petteri: identification of the stages sensitive to arteether. Exp Parasitol 1992; 75: 449–456
Soh PN et al. In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob Agents Chemother 2009; 53: 1100–1106
Jansen O et al. Antiplasmodial activity of Mezoneuron benthamianum leaves and identification of its active constituents. J Ethnopharmacol 2017; 203: 20–26
Olthof MR et al. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 2001; 131: 66–71
Wang S-J et al. Bioavailability of caffeic acid in rats and its absorption properties in the Caco-2 cell model. Pharm Biol 2014; 52: 1150–1157
Guo X et al. Antitumor activity of caffeic acid 3,4-dihydroxyphenethyl ester and its pharmacokinetic and metabolic properties. Phytomedicine 2013; 20: 904–912
Filipe HAL et al. Differential targeting of membrane lipid domains by caffeic acid and its ester derivatives. Free Radic Biol Med 2018; 115: 232–245
Wu X-W et al. Anti-inflammatory phenolic acid esters from the roots and rhizomes of Notopterygium incisium and their permeability in the human Caco-2 monolayer cell model. Molecules 2017; 22: 935
